pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
HOOKIPA Pharma Inc. ($HOOK) · news · pharmadog
← back to HOOKIPA Pharma Inc.
News mentioning $HOOK
31
stories
6d
Gubra CEO gets the quick hook; Ex-HHS official Brett Giroir takes over at cancer biotech
endpoints
7d
Windward prices $175M IPO to advance China-licensed lung drugs
biopharma dive
8d
A new tactic in the war over out-of-network bills: Health care providers are suing employers
stat
13d
‘Flying blind’: Why experts fear Treasury’s China biotech investment crackdown will backfire
fiercebiotech
17d
Drugmakers rush to pair up with Summit’s ivonescimab ahead of key verdict
biospace
21d
Labor Department finalizes sweeping PBM disclosure rule
biopharma dive
27d
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager
biospace
Oct 14, 26
Ultragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slump
endpoints
Oct 14, 26
Opinion: How states can resist the potential Trump vaccine shortages
stat
Oct 14, 26
Zealand inks $1.2B Generate pact to add multispecific proteins to obesity pipeline
fiercebiotech
Oct 13, 26
Pfizer pens $500M+ deal with Enodia to destroy disease-causing proteins
biospace
Oct 8, 26
Big Pharma–backed Matchpoint scores $150M series B, advancing autoimmune asset
biospace
Oct 8, 26
The Nobel boys club (again)
stat
Oct 8, 26
STAT+: Biotech companies are struggling to navigate Trump’s new tariffs
stat
Sep 24, 26
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
biospace
Sep 24, 26
Merck sees pivotal victory for $3B eye disease prospect
fiercebiotech
Sep 22, 26
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
biospace
Sep 21, 26
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
biospace
Sep 17, 26
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
biospace
Sep 15, 26
Opinion: 3 lessons from the tobacco settlement on how states should use money from Meta
stat
Sep 4, 26
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
biospace
Sep 3, 26
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
biospace
Aug 31, 26
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
biospace
Aug 13, 26
Opinion: How to disrupt the health misinformation business model
stat
Jul 21, 26
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
Jun 5, 26
Tiny HHS office tasked with protecting research participants’ safety is running on fumes
stat
Jun 4, 26
What happens at a longevity festival?
stat
May 18, 26
STAT+: Trump’s CMS to allow skimpier plans on ACA exchanges
stat
May 15, 26
Why isn’t alcohol seen as a public health emergency?
stat
May 9, 26
Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national news
stat
← prev
page 1 of 2
next →